|
|
|
Insider
Information: |
Aselage Steve |
Relationship: |
Director |
City: |
Fremont |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
293,421 |
|
Indirect Shares
|
19,500 |
|
|
Direct
Value |
$6,739,296 |
|
|
Indirect Value
|
$118,170 |
|
|
Total
Shares |
312,921 |
|
|
Total
Value |
$6,857,466 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
5
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
4
|
2
|
|
|
|
Gain/Loss Ratio : |
-4.0
|
1.5
|
Percentage
Gain/Loss : |
-31.1%
|
62.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cti Biopharma Corporation |
CTIC |
EVP, Global Commercial... |
2005-06-30 |
24,133 |
2004-08-03 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Business Of... |
2012-07-02 |
59,030 |
2006-04-28 |
0 |
Premium* |
|
Travere Therapeutics, Inc |
TVTX |
Director |
2022-05-11 |
146,919 |
2021-11-05 |
19,500 |
Premium* |
|
Acer Therapeutics Inc |
ACER |
Director |
2023-11-17 |
0 |
2017-09-19 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-06-13 |
63,339 |
2019-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-03-08 |
4 |
OE |
$7.16 |
$172,484 |
D/D |
24,090 |
55,361 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2012-05-15 |
4 |
OE |
$17.33 |
$173,300 |
D/D |
10,000 |
69,030 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-03 |
4 |
OE |
$17.33 |
$178,690 |
D/D |
10,311 |
41,789 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2008-01-02 |
4 |
AS |
$35.28 |
$180,398 |
D/D |
(5,000) |
7,034 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-12-02 |
4 |
S |
$23.43 |
$184,849 |
D/D |
(7,891) |
202,216 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-06-25 |
4 |
AS |
$20.00 |
$200,000 |
D/D |
(10,000) |
238,732 |
0 |
% |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-11-17 |
4 |
S |
$25.75 |
$206,000 |
D/D |
(8,000) |
29,881 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-03-02 |
4 |
S |
$21.00 |
$210,000 |
D/D |
(10,000) |
41,271 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-03-03 |
4 |
S |
$21.00 |
$210,000 |
D/D |
(10,000) |
31,271 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev. |
|
2007-09-14 |
4 |
S |
$22.40 |
$224,000 |
D/D |
(10,000) |
4,895 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-10-28 |
4 |
OE |
$14.39 |
$242,831 |
D/D |
16,875 |
63,353 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-25 |
4 |
S |
$27.00 |
$247,779 |
D/D |
(9,177) |
43,978 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-02-02 |
4 |
OE |
$10.09 |
$252,250 |
D/D |
25,000 |
221,667 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-04-16 |
4 |
AS |
$26.23 |
$262,300 |
D/D |
(10,000) |
188,940 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-11-05 |
4 |
AS |
$26.23 |
$262,300 |
D/D |
(10,000) |
161,794 |
0 |
% |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-03 |
4 |
S |
$27.15 |
$279,895 |
D/D |
(10,311) |
31,478 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Ops |
|
2007-02-14 |
4 |
AS |
$20.00 |
$300,000 |
D/D |
(15,000) |
2,829 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2012-05-11 |
4 |
OE |
$14.39 |
$324,480 |
D/D |
21,530 |
68,340 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2018-08-31 |
4 |
AS |
$32.00 |
$384,000 |
D/D |
(12,000) |
245,883 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2012-05-15 |
4 |
S |
$38.64 |
$386,373 |
D/D |
(10,000) |
59,030 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2007-08-10 |
4 |
S |
$20.21 |
$405,389 |
D/D |
(20,000) |
4,895 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-09-08 |
4 |
OE |
$11.74 |
$410,900 |
D/D |
35,000 |
72,587 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-11-18 |
4 |
OE |
$14.39 |
$451,486 |
D/D |
31,375 |
61,756 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-11-06 |
4 |
AS |
$23.00 |
$474,375 |
D/D |
(20,625) |
213,107 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-03-17 |
4 |
AS |
$27.35 |
$486,456 |
D/D |
(17,727) |
188,940 |
0 |
% |
|
169 Records found
|
|
Page 6 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|